Nuvalent, Inc. (NUVL)
102.12
+0.88
(+0.87%)
USD |
NASDAQ |
May 22, 16:00
102.07
-0.05
(-0.05%)
After-Hours: 20:00
Nuvalent EPS Diluted (Quarterly) : -1.389 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.60 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Olema Pharmaceuticals, Inc. | -0.5164 |
| Vera Therapeutics, Inc. | -1.693 |
| Tyra Biosciences, Inc. | -0.6366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -109.28M |
| Total Expenses (Quarterly) | 109.28M |
| Enterprise Value | 6.780B |
| Earnings Yield | -5.93% |
| Normalized Earnings Yield | -5.408 |